Kidney biopsies are a common test to diagnose kidney disease. Doctors use a needle to take a tiny sample of tissue. This procedure carries a small risk of bleeding or other complications. A large review looked at 68 series of these biopsies to see if needle size matters. The researchers compared 16-gauge needles to 18-gauge needles. These needles are used in real-time ultrasound-guided biopsies. The goal was to find if a smaller needle is safer or better.
The data showed that major complication rates were low for both needle sizes. The rate for 16-gauge needles was 1.83 percent. The rate for 18-gauge needles was 1.29 percent. The difference was small and likely due to how the studies were done rather than the needle itself. Diagnostic yield, or how much useful tissue was collected, was also similar. The mean glomerular yield was 18.8 for the smaller needle and 17.5 for the larger one.
However, the evidence has limits. Most studies were single-arm cohorts, meaning they did not directly compare the two needle sizes in the same patients. Definitions and reporting varied across the studies. The retrospective design means the data came from past records rather than a planned experiment. Because of this, we cannot say for sure that one needle is definitively better than the other. Direct comparative studies are needed to determine whether meaningful differences exist. Overall, both options appear safe and effective for adults.